NasdaqCM - Nasdaq Real Time Price USD

Augmedix, Inc. (AUGX)

Compare
2.3250 -0.0050 (-0.21%)
As of 9:30 AM EDT. Market Open.
Loading Chart for AUGX
DELL
  • Previous Close 2.3300
  • Open 2.3200
  • Bid 2.3100 x 200
  • Ask 2.3500 x 200
  • Day's Range 2.3200 - 2.3250
  • 52 Week Range 0.7300 - 6.2500
  • Volume 2,184
  • Avg. Volume 899,385
  • Market Cap (intraday) 114.92M
  • Beta (5Y Monthly) -0.19
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4700
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.52

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.

www.augmedix.com

1,430

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AUGX

View More

Performance Overview: AUGX

Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AUGX
60.26%
S&P 500
14.98%

1-Year Return

AUGX
52.74%
S&P 500
23.03%

3-Year Return

AUGX
53.41%
S&P 500
22.05%

5-Year Return

AUGX
53.50%
S&P 500
38.04%

Compare To: AUGX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AUGX

View More

Valuation Measures

Annual
As of 9/9/2024
  • Market Cap

    115.17M

  • Enterprise Value

    112.22M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.27

  • Price/Book (mrq)

    11.00

  • Enterprise Value/Revenue

    2.18

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -46.23%

  • Return on Assets (ttm)

    -30.61%

  • Return on Equity (ttm)

    -329.78%

  • Revenue (ttm)

    51.58M

  • Net Income Avi to Common (ttm)

    -23.85M

  • Diluted EPS (ttm)

    -0.4700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.22M

  • Total Debt/Equity (mrq)

    241.31%

  • Levered Free Cash Flow (ttm)

    -11.66M

Research Analysis: AUGX

View More

Company Insights: AUGX

Research Reports: AUGX

View More

People Also Watch